A comparison of the respiratory effects of sevoflurane and halothane in infants and young children.
BACKGROUND
This study compared the respiratory effects of sevoflurane with those of halothane in anesthetized infants and young children.


METHODS
Infants were randomized to receive 1 minimum alveolar concentration (MAC) halothane or sevoflurane in a mixture of nitrous oxide and oxygen. Anesthetic management included the use of a laryngeal mask. Flow, airway pressure, and the end-tidal carbon dioxide pressure (PETCO2) were measured during spontaneous ventilation and airway occlusions. Respiratory inductive plethysmography was used to assess chest wall motion.


RESULTS
Measurements were obtained in 30 infants and young children (mean (SD) age, 14.5 (5.9) months), 15 of whom received sevoflurane and 15 received halothane. Some respiratory depression, as indicated by a PETCO2 of 45 mmHg (6 kPa), was present in both groups. Minute ventilation and respiratory frequency were significantly lower during sevoflurane than halothane anesthesia (4.5 compared with 5.4 (1/ m2)/min, and 37.5 compared with 46.7 breaths/min, respectively, P < 0.05). There was no difference in respiratory drive, but the shape of the flow waveform differed according to anesthetic agent, with peak inspiratory flow reached later, and peak expiratory flow reached earlier, in the sevoflurane group. There was also significantly less thoracoabdominal asynchrony during sevoflurane anesthesia.


CONCLUSIONS
Minute ventilation and respiratory frequency were lower in infants during 1 MAC sevoflurane in nitrous oxide than during halothane anesthesia. However, these differences may not be clinically relevant at these concentrations, given the modest increase in PETCO2. Differences in parameters of breath timing and shape between sevoflurane and halothane suggest different effects of these anesthetic agents on ventilatory control.
Brown
K
K
Portex Anaesthesia, Intensive Therapy and Respiratory Medicine Unit, Institute of Child Health, London, United Kingdom.
Aun
C
C
Stocks
J
J
Jackson
E
E
Mackersie
A
A
Hatch
D
D
D018685:Anesthetics, Inhalation / Q000008:administration & dosage* / Q000009:adverse effects*; D002675:Child, Preschool; D005121:Extremities / Q000601:surgery*; D006221:Halothane / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008738:Methyl Ethers / Q000008:administration & dosage* / Q000009:adverse effects*; D010146:Pain / Q000517:prevention & control*; D012143:Respiratory Physiological Phenomena; D012137:Respiratory System / Q000187:drug effects*; D000077149:Sevoflurane
D018685:Anesthetics, Inhalation; D008738:Methyl Ethers; D000077149:Sevoflurane; D006221:Halothane